Health Care/Hospital

China Jo-Jo Drugstores Hosts the First Suppliers Conference in China

HANGZHOU, China, Jan. 21, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the...

2021-01-21 21:30

The 5th China Health Industry Development Forum Held in Panzhihua

PANZHIHUA, China, Jan. 20, 2021 /PRNewswire/ -- The 5th China Health Industry Development Forum, themed with "What Can the Health Industry Do for a Healthy China", was hosted in the Chinese city of Panzhihua onJanuary 18. At the forum that was organized by the Panzhihua Municipal People's Gover...

2021-01-20 20:02 697

Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody JMB2002

NANCHANG, China, Jan. 20, 2021 /PRNewswire/ -- On January 15, Jemincare Group, a Chinese pharmaceutical company, announced that it has initiated the phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody (JMB2002). Preclinical studies of JMB2002 including pharmacology and toxicity were ...

2021-01-20 13:53 483

Medibio Granted CE Mark Approval for MEBsleep

MINNEAPOLIS, Jan. 19, 2021 /PRNewswire/ -- Medibio Limited (MEB or the Company )(ASX: MEB)(OTCPINK: MDBIF), is pleased to announce that it has received CE Mark approval for its sleep staging software, MEBsleep. MEBsleep is a software-only medical device that analyses Electroencephalogram (EEG) ...

2021-01-19 21:06 1648

Gracell Biotechnologies Receives IND Approval from China NMPA for GC019F, a FasTCAR-Enabled CAR-T Therapy for the Treatment of Relapsed or Refractory Adult B-ALL

SUZHOU and SHANGHAI, China, Jan. 19, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the Nati...

2021-01-19 19:30 1774

Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy

WUHAN, China and NEWARK, DE., Jan. 19, 2021 /PRNewswire/ -- Neurophth Therapeutics, Inc., a subsidiary of Wuhan Neurophth Biotechnology Ltd. gene therapy company (hereafter Neurophth), and AAVnerGene Inc., a specializing AAV technology company, today announced a strategic partnership to provide ...

2021-01-19 14:05 457

CES 2021 Taiwanese Startup, VitalSigns Technology, Debuting at CES with Remarkable Air Quality Monitoring IoT Device

TAIPEI, Jan. 18, 2021 /PRNewswire/ -- Following its previous successes in bio-signal monitors and connective health, VitalSigns Technology shifted gears and entered the IoT industry with its outstanding biosensor and physiological monitoring development capabilities. Its professional air quality ...

2021-01-19 00:00 986

CES 2021 Taiwan's First Telerehab System Anticipates High Demand for Remote Healthcare during the COVID-19 Pandemic

TAIPEI, Jan. 18, 2021 /PRNewswire/ --  Hospitals and healthcare systems across the world are looking at telehealth strategies to connect with patients in remote locations. This trend has only accelerated during theCOVID-19 pandemic. With heavy risks from in-person medical checkups, it is anticipa...

2021-01-18 22:00 719

Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy

SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELPTM platform to develop next-generation gene therapies. This new collaboration combines Boeh...

2021-01-18 22:00 751

TenNor Enters Research Collaboration with Janssen for Potential New Treatments for Nontuberculous Mycobacteria Diseases

SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases associated with bacterial infections and dysbioses, announced today that it ...

2021-01-18 21:00 611

ZhenMeiHui Self-healing Rejuvenation Technology Continues to Look Good Despite the Fast-changing Aesthetic Medicine Industry in China

SHANGHAI, Jan. 18, 2021 /PRNewswire/ -- On May 19, the iResearch Services, a firm of data research, released theWhite Paper on Insights into the Chinese Aesthetic Medicine Industry in 2020(hereinafter referred to as the "White Paper"). According to the document,China's aesthetic medicine market s...

2021-01-18 17:36 583

CES 2021 ELECLEAN Disinfectant Recognized by WHO Regional Office as an Innovative Technology in the Fight against COVID-19

TAIPEI, Taiwan, Jan. 17, 2021 /PRNewswire/ -- The World Health Organization's Regional Office forAfrica has compiled a worldwide database of COVID-19 technological innovations with the goal of sharing information on technologies that have already made a difference in other parts of the world. Dev...

2021-01-17 19:15 968

CES 2021 MedFluid Develops First-In-Class Microfluidic Platform for Rapid Detection and Screening of Disease Diagnosis

TAIPEI, Taiwan, Jan. 17, 2021 /PRNewswire/ -- Health and Biotech company MedFluid has developed the fastest, first-in-class antimicrobial susceptibility test that will aid in providing precise medical prescriptions to improve the health and well-being of patients.

2021-01-17 18:02 978

COVID-19 vaccines: Common solution, not competition

BEIJING, Jan. 15, 2021 /PRNewswire/ -- A news report by China.org.cn on China's COVID-19 vaccines:   At the end of 2020, one of China's self-developed COVID-19 vaccines was granted conditional approval for general use by the National Medical Products Administration. Previously,...

2021-01-15 22:01 3532

Senhwa Biosciences Presents Positive Cholangiocarcinoma Data

TAIPEI and SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announces that promising clinical data from their global phase...

2021-01-15 22:00 1825

Gracell Biotechnologies Receives Medical Products Manufacturing Certificate for CAR-T Cell Therapy Products

SUZHOU, China, Jan. 15, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, has been granted the Medical Products Manuf...

2021-01-15 21:00 1849

CES 2021 Taiwanese Startup ACSI Gives New Technological Shine to Traditional Chinese Medical Treatments

TAIPEI, Jan. 15, 2021 /PRNewswire/ -- Chinese medicine has been receiving increased attention worldwide. These traditional therapeutic treatments are now being combined with modern technology and integrated into Western medicine. Acupuncture, for example, is being widely adopted and trusted by pa...

2021-01-15 14:35 711

Huami to Host 2021 Strategy and Outlook Investor Fireside Chat with CEO Wang Huang on January 22

BEIJING, Jan. 14, 2021 /PRNewswire/ -- Huami Corp. (NYSE: HMI) today announced that it will hold a Fireside Chat conference call for investors on Friday,22 January 2021. The company will discuss its 2021 strategies for consumer and industrial health technologies, including its product plans annou...

2021-01-14 19:00 8398

CES 2021 Mission for the human race, Pulxion's early detection technology is here to save lives

TAIPEI, Jan. 14, 2021 /PRNewswire/ -- In the new era of medical technology, Pulxion Medical Technology Co., Ltd. aims to create a personalized mobile hospital to enable early detection and achieve preventive healthcare in everyday life. Pulxion's first product, PulStroke, is a novel fast-screenin...

2021-01-14 16:04 563

Samsung Biologics Shares 'Vision' for Next Decade at the 39th Annual JP Morgan Healthcare Conference

INCHEON, South Korea, Jan. 13, 2021 /PRNewswire/ -- Samsung Biologics (207940.KS) set forth its dynamic growth plan for the next decade at the 2021 Annual JP Morgan Healthcare Conference.John Rim, newly appointed President and CEO, unveiled a multidimensional business plan for the company to furt...

2021-01-13 23:17 5987
12345 ... 577